{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:07:50Z","timestamp":1791043670453,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1124\/dmd.113.052126","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T05:36:48Z","timestamp":1370324208000},"page":"1752-1762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Expression Variability of Absorption, Distribution, Metabolism, Excretion\u2013Related MicroRNAs in Human Liver: Influence of Nongenetic Factors and Association with Gene Expression"],"prefix":"10.1016","volume":"41","author":[{"given":"Jessica K.","family":"Rieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich M.","family":"Zanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.052126_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/187152012802650273","article-title":"MicroRNAs in cancer: small molecules, big chances","volume":"12","author":"Abba","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1124\/dmd.113.052126_bib2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1101\/gr.2845604","article-title":"MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues","volume":"14","author":"Barad","year":"2004","journal-title":"Genome Res"},{"key":"10.1124\/dmd.113.052126_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1124\/dmd.113.052126_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1261\/rna.7240905","article-title":"Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes","volume":"11","author":"Baskerville","year":"2005","journal-title":"RNA"},{"key":"10.1124\/dmd.113.052126_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"Braconi","year":"2010","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052126_bib6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/mol.104.009019","article-title":"Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor","volume":"67","author":"Burk","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.052126_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/emmm.201201986","article-title":"MicroRNAs in age-related diseases","volume":"5","author":"Dimmeler","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1124\/dmd.113.052126_bib8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1124\/dmd.110.033886","article-title":"Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes","volume":"38","author":"Feidt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052126_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1124\/dmd.113.052126_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/pgs.09.7","article-title":"Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation","volume":"10","author":"Gomes","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.113.052126_bib11","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.113.052126_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S000629791301001X","article-title":"Nucleic acids in exosomes: disease markers and intercellular communication molecules","volume":"78","author":"Gusachenko","year":"2013","journal-title":"Biochemistry (Mosc)"},{"key":"10.1124\/dmd.113.052126_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2407-11-81","article-title":"Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells","volume":"11","author":"Habano","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1124\/dmd.113.052126_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.fpc.0000171517.22258.f1","article-title":"Three haplotypes associated with CYP2A6 phenotypes in Caucasians","volume":"15","author":"Haberl","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.052126_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.133306","article-title":"Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver","volume":"325","author":"Hofmann","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.052126_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.113.052126_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2010.07.012","article-title":"MicroRNA-34a regulation of endothelial senescence","volume":"398","author":"Ito","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.113.052126_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/1078-0432.CCR-07-0523","article-title":"Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival","volume":"14","author":"Jiang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.113.052126_bib19","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.biochi.2012.07.013","article-title":"DNA methylation dynamics in the hepatic CYP3A4 gene promoter","volume":"94","author":"Kacevska","year":"2012","journal-title":"Biochimie"},{"key":"10.1124\/dmd.113.052126_bib20","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s11095-011-0473-y","article-title":"PPAR\u03b1 is regulated by miR-21 and miR-27b in human liver","volume":"28","author":"Kida","year":"2011","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.113.052126_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/clpt.2011.336","article-title":"PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo","volume":"91","author":"Klein","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.052126_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fphar.2010.00129","article-title":"Pathway-targeted pharmacogenomics of CYP1A2 in human liver","volume":"1","author":"Klein","year":"2010","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.113.052126_bib23","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/MCB.01228-12","article-title":"The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation","volume":"33","author":"Kumar","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.113.052126_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol"},{"key":"10.1124\/dmd.113.052126_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"key":"10.1124\/dmd.113.052126_bib26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hep.25613","article-title":"Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis","volume":"56","author":"Lakner","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052126_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"Landgraf","year":"2007","journal-title":"Cell"},{"key":"10.1124\/dmd.113.052126_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","article-title":"Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver","volume":"11","author":"Lang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.113.052126_bib29","first-page":"527","article-title":"Controlling SIRT1 expression by microRNAs in health and metabolic disease","volume":"2","author":"Lee","year":"2010","journal-title":"Aging (Albany, NY Online)"},{"key":"10.1124\/dmd.113.052126_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mad.2010.12.004","article-title":"Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1","volume":"132","author":"Li","year":"2011","journal-title":"Mech Ageing Dev"},{"key":"10.1124\/dmd.113.052126_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/leu.2011.273","article-title":"An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-\u03b1 and cAMP\/PKA pathways","volume":"26","author":"Lv","year":"2012","journal-title":"Leukemia"},{"key":"10.1124\/dmd.113.052126_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jcp.21834","article-title":"Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts","volume":"221","author":"Maes","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1124\/dmd.113.052126_bib33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bcp.2009.11.015","article-title":"Human CYP2E1 is regulated by miR-378","volume":"79","author":"Mohri","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.052126_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.2008.302","article-title":"Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics","volume":"85","author":"Morgan","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.052126_bib35","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/dmd.113.052126_bib36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.23103","article-title":"Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver","volume":"50","author":"Nies","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052126_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm405","article-title":"Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1","volume":"5","author":"Nies","year":"2013","journal-title":"Genome Med"},{"key":"10.1124\/dmd.113.052126_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.taap.2012.02.012","article-title":"Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by miR-24","volume":"260","author":"Oda","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.113.052126_bib39","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs regulate CYP3A4 expression via direct and indirect targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052126_bib40","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1158\/0008-5472.CAN-08-1768","article-title":"Emerging role of miR-106b-25\/miR-17-92 clusters in the control of transforming growth factor beta signaling","volume":"68","author":"Petrocca","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.052126_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bbagen.2006.09.024","article-title":"The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks","volume":"1770","author":"Plant","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.113.052126_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/dmd.111.040329","article-title":"In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4\u03b1 expression","volume":"40","author":"Ramamoorthy","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.052126_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/187231211795305258","article-title":"In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genes","volume":"5","author":"Ramamoorthy","year":"2011","journal-title":"Drug Metab Lett"},{"key":"10.1124\/dmd.113.052126_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fgene.2011.00039","article-title":"MIRNA-DISTILLER: A Stand-Alone Application to Compile microRNA Data from Databases","volume":"2","author":"Rieger","year":"2011","journal-title":"Front Genet"},{"key":"10.1124\/dmd.113.052126_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/tpj.2011.44","article-title":"Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver","volume":"13","author":"Schr\u00f6der","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.113.052126_bib46","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1210\/me.2009-0117","article-title":"MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1","volume":"23","author":"Strum","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.113.052126_bib47","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.052126_bib48","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.M709382200","article-title":"Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4","volume":"283","author":"Takagi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.113.052126_bib49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/mol.112.082503","article-title":"Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPAR\u03b1)","volume":"83","author":"Thomas","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.052126_bib50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.fpc.0000230112.96086.e0","article-title":"Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events","volume":"16","author":"Toscano","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.113.052126_bib51","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-06-1403","article-title":"MicroRNA regulates the expression of human cytochrome P450 1B1","volume":"66","author":"Tsuchiya","year":"2006","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.052126_bib52","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1261\/rna.965408","article-title":"miRDB: a microRNA target prediction and functional annotation database with a wiki interface","volume":"14","author":"Wang","year":"2008","journal-title":"RNA"},{"key":"10.1124\/dmd.113.052126_bib53","doi-asserted-by":"crossref","first-page":"e59141","DOI":"10.1371\/journal.pone.0059141","article-title":"No correlation of hsa-miR-148a with expression of PXR or CYP3A4 in human livers from Chinese Han population","volume":"8","author":"Wei","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1124\/dmd.113.052126_bib54","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.1840380424","article-title":"Sex is a major determinant of CYP3A4 expression in human liver","volume":"38","author":"Wolbold","year":"2003","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.052126_bib55","doi-asserted-by":"crossref","first-page":"e30250","DOI":"10.1371\/journal.pone.0030250","article-title":"Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis","volume":"7","author":"Yamaura","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/dmd.113.052126_bib56","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.103341.109","article-title":"Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver","volume":"20","author":"Yang","year":"2010","journal-title":"Genome Res"},{"key":"10.1124\/dmd.113.052126_bib57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-pharmtox-011112-140250","article-title":"microRNAs as mediators of drug toxicity","volume":"53","author":"Yokoi","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.113.052126_bib58","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008571-200110000-00004","article-title":"Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6","volume":"11","author":"Zanger","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.113.052126_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.113.052126_bib60","doi-asserted-by":"crossref","first-page":"e23506","DOI":"10.1371\/journal.pone.0023506","article-title":"Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624098672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624098672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.052126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:13:33Z","timestamp":1739906013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624098672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090955624098672"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.052126","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression Variability of Absorption, Distribution, Metabolism, Excretion\u2013Related MicroRNAs in Human Liver: Influence of Nongenetic Factors and Association with Gene Expression","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.052126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}